These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 32488849)
1. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway. Jeong YJ; Hwang SK; Magae J; Chang YC Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849 [TBL] [Abstract][Full Text] [Related]
2. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells. Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173 [TBL] [Abstract][Full Text] [Related]
3. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells. Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035 [TBL] [Abstract][Full Text] [Related]
4. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [TBL] [Abstract][Full Text] [Related]
5. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis. Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809 [TBL] [Abstract][Full Text] [Related]
6. Ascofuranone inhibits epidermal growth factor-induced cell migration by blocking epithelial-mesenchymal transition in lung cancer cells. Kim HW; Jeong YJ; Hwang SK; Park YY; Choi YH; Kim CH; Magae J; Chang YC Eur J Pharmacol; 2020 Aug; 880():173199. PubMed ID: 32439259 [TBL] [Abstract][Full Text] [Related]
7. Rapid activation of FAK/mTOR/p70S6K/PAK1-signaling controls the early testosterone-induced actin reorganization in colon cancer cells. Gu S; Kounenidakis M; Schmidt EM; Deshpande D; Alkahtani S; Alarifi S; Föller M; Alevizopoulos K; Lang F; Stournaras C Cell Signal; 2013 Jan; 25(1):66-73. PubMed ID: 23316499 [TBL] [Abstract][Full Text] [Related]
8. Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling. Khan ZS; Hussain F Cell Physiol Biochem; 2024 Jun; 58(3):250-272. PubMed ID: 38865588 [TBL] [Abstract][Full Text] [Related]
9. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Yun J; Shin HK; Song SH; Kim JH; Lee JS; Kim CD; Bae SS Oncogene; 2011 Jun; 30(26):2954-63. PubMed ID: 21339740 [TBL] [Abstract][Full Text] [Related]
10. A Potential Combination of Targeting HSP90 and mTOR in Breast Cancer Cell Growth, Migration, and Invasion Through Inhibiting AKT Phosphorylation and F-actin Organization. Suwannalert P; Panpinyaporn P; Wantanachaisaeng P; Teeppaibul T; Khumsri W; Koomsang T; Payuhakrit W; Naktubtim C Anticancer Res; 2024 Jun; 44(6):2555-2565. PubMed ID: 38821604 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Liu L; Chen L; Chung J; Huang S Oncogene; 2008 Aug; 27(37):4998-5010. PubMed ID: 18504440 [TBL] [Abstract][Full Text] [Related]
12. PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway. Xing X; Zhang L; Wen X; Wang X; Cheng X; Du H; Hu Y; Li L; Dong B; Li Z; Ji J Anticancer Drugs; 2014 Nov; 25(10):1129-40. PubMed ID: 25035961 [TBL] [Abstract][Full Text] [Related]
13. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423 [TBL] [Abstract][Full Text] [Related]
14. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines. Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of petasin on human colon carcinoma cells mediated by inactivation of Akt/mTOR pathway. Lyu X; Song AL; Bai YL; Xu XD; He DQ; Zhang YC Chin Med J (Engl); 2019 May; 132(9):1071-1078. PubMed ID: 30896562 [TBL] [Abstract][Full Text] [Related]
16. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related]
17. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition. Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617 [TBL] [Abstract][Full Text] [Related]
19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
20. Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway. Neoh CA; Wu WT; Dai GF; Su JH; Liu CI; Su TR; Wu YJ Molecules; 2017 Dec; 23(1):. PubMed ID: 29280977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]